We are live on
!
Find out more
BP
Ballentine Partners Portfolio holdings
AUM
$8.18B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
-15.76%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$2.83B
AUM Growth
-$365M
(-11%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
63.82%
Holding
492
New
23
Increased
173
Reduced
193
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$38M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$38M |
| 3 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$21.1M |
| 4 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$14.9M |
| 5 |
iShares Core MSCI Europe ETF
IEUR
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$18M |
| 2 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$8.08M |
| 3 |
iShares Gold Trust
IAU
|
+$1.39M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$1.37M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.59% |
| 2 | Healthcare | 2.1% |
| 3 | Financials | 2.01% |
| 4 | Consumer Discretionary | 1.12% |
| 5 | Consumer Staples | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares Europe ETF
IEV
$1.67B
| $1.03M | 0.04% |
24,170
| – | – |
|
152
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
| $1.03M | 0.04% |
10,700
| – | – |
|
153
Chubb
CB
$135B
| $1.03M | 0.04% |
5,219
-155
| -3% | -$31.9K |
|
154
Verisk Analytics
VRSK
$25.4B
| $1.02M | 0.04% |
5,869
+2,086
| +55% | +$389K |
|
155
Sysco
SYY
$40.8B
| $1.01M | 0.04% |
11,942
-723
| -6% | -$60.6K |
|
156
Morgan Stanley
MS
$331B
| $1.01M | 0.04% |
13,284
+566
| +4% | +$46.4K |
|
157
General Mills
GIS
$19.1B
| $1.01M | 0.04% |
13,381
-11,166
| -45% | -$782K |
|
158
Broadcom
AVGO
$1.85T
| $945K | 0.03% |
19,470
+2,410
| +14% | +$135K |
|
159
Starbucks
SBUX
$120B
| $932K | 0.03% |
12,202
-2,663
| -18% | -$205K |
|
160
Medtronic
MDT
$109B
| $925K | 0.03% |
10,297
-2,651
| -20% | -$269K |
|
161
GSK
GSK
$104B
| $915K | 0.03% |
16,817
-4,311
| -20% | -$238K |
|
162
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
| $902K | 0.03% |
6,019
-398
| -6% | -$65.3K |
|
163
Alibaba
BABA
$293B
| $883K | 0.03% |
7,761
-319
| -4% | -$31.3K |
|
164
Hershey
HSY
$35.2B
| $878K | 0.03% |
4,080
+2,028
| +99% | +$442K |
|
165
Linde
LIN
$221B
| $866K | 0.03% |
3,015
-196
| -6% | -$61.2K |
|
166
Becton Dickinson
BDX
$45.6B
| $856K | 0.03% |
3,473
-937
| -21% | -$238K |
|
167
Emerson Electric
EMR
$83.9B
| $851K | 0.03% |
10,689
-1,034
| -9% | -$91.2K |
|
|
SCHW
168
Charles Schwab
SCHW
$183B
| $831K | 0.03% |
13,153
+63
| +0.5% | +$4.34K |
|
169
Vanguard Total World Stock ETF
VT
$77.1B
| $826K | 0.03% |
9,682
+40
| +0.4% | +$3.7K |
|
170
Target
TGT
$65.6B
| $825K | 0.03% |
5,841
-736
| -11% | -$141K |
|
171
S&P Global
SPGI
$121B
| $824K | 0.03% |
2,445
-1,179
| -33% | -$420K |
|
172
US Bancorp
USB
$98.2B
| $823K | 0.03% |
17,887
-5,220
| -23% | -$261K |
|
173
CVS Health
CVS
$133B
| $821K | 0.03% |
8,859
-165
| -2% | -$16.1K |
|
174
Lam Research
LRCX
$367B
| $821K | 0.03% |
19,270
+560
| +3% | +$26.7K |
|
|
NVO
175
Novo Nordisk
NVO
$208B
| $816K | 0.03% |
14,642
+1,346
| +10% | +$74.7K |
|
Similar funds
LGF
OC
CCM
CL
WJWM
WA
CCM
AIM
Ballentine Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Ballentine Partners held 492 positions worth $2.83B, down 11% from $3.19B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Ballentine Partners deployed $156M of net new capital in Q2 2022, opening 23 new positions and adding to 173 existing holdings. Its largest new stake was Harbor Dividend Growth Leaders ETF: 384,894 shares worth $4.61M.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $18M trimmed.
- Ballentine Partners's largest Q2 2022 buy was Harbor Dividend Growth Leaders ETF: 384,894 shares worth $4.61M.
- Ballentine Partners added most to iShares Core S&P Total US Stock Market ETF in Q2 2022, an estimated $38M increase.
- Ballentine Partners's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $18M.
- Ballentine Partners fully exited Vanguard Tax-Exempt Bond Index Fund in Q2 2022, selling an estimated $548K.
- Ballentine Partners's ten largest holdings make up 64% of its $2.83B portfolio in Q2 2022.
- Ballentine Partners opened 23 new positions and closed 56 in Q2 2022.
- Ballentine Partners's portfolio value fell 11% quarter-over-quarter to $2.83B.
Based on Ballentine Partners's 13F filing for Q2 2022, filed 9 Aug 2022.